Sosei to Acquire Idorsia’s Japan and Korea Arms for 65 Billion Yen

Sosei Group said on July 20 that it will be acquiring all shares of the Japanese and South Korean arms of Switzerland-based Idorsia Pharmaceuticals for roughly 65 billion yen, making them wholly owned subsidiaries. Under this deal, Sosei will obtain...read more